As of 2025-08-11, the EV/EBITDA ratio of Rapt Therapeutics Inc (RAPT) is -1.51. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. RAPT's latest enterprise value is 162.26 mil USD. RAPT's TTM EBITDA according to its financial statements is -107.73 mil USD. Dividing these 2 quantities gives us the above RAPT EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | EV/EBITDA |
| 2025-08-08 | -1.51 |
| 2025-08-07 | -1.57 |
| 2025-08-06 | -1.53 |
| 2025-08-05 | -1.55 |
| 2025-08-04 | -1.65 |
| 2025-08-01 | -1.61 |
| 2025-07-31 | -1.66 |
| 2025-07-30 | -1.74 |
| 2025-07-29 | -1.77 |
| 2025-07-28 | -1.95 |
| 2025-07-25 | -2.04 |
| 2025-07-24 | -1.94 |
| 2025-07-23 | -2.14 |
| 2025-07-22 | -1.89 |
| 2025-07-21 | -1.80 |
| 2025-07-18 | -1.79 |
| 2025-07-17 | -1.57 |
| 2025-07-16 | -1.62 |
| 2025-07-15 | -1.63 |
| 2025-07-14 | -1.34 |
| 2025-07-11 | -1.30 |
| 2025-07-10 | -1.32 |
| 2025-07-09 | -1.30 |
| 2025-07-08 | -1.23 |
| 2025-07-07 | -1.25 |
| 2025-07-03 | -1.24 |
| 2025-07-02 | -1.23 |
| 2025-07-01 | -1.13 |
| 2025-06-30 | -1.23 |
| 2025-06-27 | -1.29 |
| 2025-06-26 | -1.49 |
| 2025-06-25 | -1.47 |
| 2025-06-24 | -1.26 |
| 2025-06-23 | -1.14 |
| 2025-06-20 | -1.14 |
| 2025-06-18 | -1.14 |
| 2025-06-17 | -1.20 |
| 2025-06-16 | -1.27 |
| 2025-06-13 | -1.28 |
| 2025-06-12 | -1.34 |
| 2025-06-11 | -1.35 |
| 2025-06-10 | -1.46 |
| 2025-06-09 | -1.47 |
| 2025-06-06 | -1.44 |
| 2025-06-05 | -1.25 |
| 2025-06-04 | -1.25 |
| 2025-06-03 | -1.21 |
| 2025-06-02 | -1.15 |
| 2025-05-30 | -1.09 |
| 2025-05-29 | -1.14 |